|
Name | Main functions | Mechanism | Adverse events |
|
Arteether | Antiparasites | Plasmodium | Inducing iron-dependent free radicals’ generation | Anorexia Cardiovascular symptom Embryotoxicity Immunosuppressive activity neurotoxicity |
Schistosoma | Reducing glycogen content and alkaline phosphatase activity |
Toxoplasma gondii | Unknown |
Anticancer | Tumor of the central nervous system | Inducing iron-dependent cell death |
Antifungi | Cryptococcus neoformans | Unknown |
|
Artelinic acid | Antiparasites | Plasmodium | Unknown | Anemia Embryotoxicity Neurotoxicity Nephrotoxicity Reticulocytopenia Vascular irritation |
|
Artemether | Antiparasites | Plasmodium | Increasing production of reactive oxygen intermediates and reactive nitrogen intermediates | Anemia Clastogenic potential Distal tubular ectasia Emesia Endocrine disruption Fetal growth retardation Flattened epithelium in the kidney Haemolytic anemia Hemolysis Hepatocellular hypertrophy Hepatotoxicity High liver weight Immunosuppressive activity Increases in hemoglobin levels Meningeal inflammation Neurotoxicity Prolonged QT interval Reduction in fetal body weight Reduced oxytocin-induced contraction of uterine tissues Slight damage to the proprius layer lamina of intestinal villi Suppression of humoral responses Transient focal vesicle degeneration of the liver |
Acanthamoeba castellanii | Be used as a hosphoglycerate dehydrogenase inhibitor |
Schistosoma | (1) Affecting both carbohydrate and protein metabolism of schistosomes; (2) By inhibition of GST and SOD enzymes, leading to increased schistosome susceptibility to oxidant attacks |
Toxoplasma gondii | By affecting the glucose-6-phosphatase of T. gondii, resulting in the energy metabolism of the parasite |
Anticancer | Pituitary macroadenoma | Unknown |
Glioma | Inhibiting the migration, invasiveness, expression of MMP-2/MMP-9 and p-Akt significantly while also promoting the apoptosis of tumor cells |
Anti-inflammation | Neuroinflammation | Inducing Nrf2 expression which results in the anti-inflammatory effect |
Antivirus | Cytomegalovirus | Unknown |
|
Artemisinin | Antiparasites | Plasmodium | Generating highly reactive carbon-centered radicals via endoperoxide cleavage | Anemia Anorexia Cholestatic liver injury Genital system injury Hepatitis Immunosuppressive activity Neurotoxicity Ptyalism |
Schistosoma | Unknown |
Toxoplasma gondii | (1) Inhibiting the intracellular growth of T. gondii in vitro by imposing oxidative stress within the cells (2) Perturbing calcium homeostasis in T. gondii |
Trypanosoma | Inhibiting calcium-dependent ATPase activity in T. cruzi membranes |
Anticancer | Brain tumor | (1) Bringing about reactive oxygen species-mediated action (2) Inducing iron-dependent cell death |
Anti-inflammation | Alzheimer’s disease | Suppressing NF-κB activity and NALP3 inflammasome activation |
Antifungi | C. neoformans | Unknown |
C. albicans | Unknown |
Antivirus | Cytomegalovirus | Modulating cell cycle through CDKs and pRb |
Herpes virus | Unknown |
Others | Schizophrenia | Reducing levels of antibodies to gliadin |
Neurite outgrowth | Activating ERK and p38 MAPK signaling pathways |
Vascular | (1) Inhibiting VSMC migration through down-regulation of ERK1/2 and MMP9 phosphorylation (2) Inhibiting the inflammation of VSMCs induced by TNF-α through ROS-mediated NF-κB signal pathway |
|
Artesunate | Antiparasites | Plasmodium | (1) Inhibiting the activity of the cytochrome oxidase (2) Increasing oxidant stress on the infected red cells | Anaphylaxis Anemia Cardiovascular system Contragestational action Haemolysis Immunosuppressive activity Neurotoxicity |
Echinococcus | Unknown |
Heterophyid | Unknown |
Schistosoma | Reducing expression of schistosome thioredoxin glutathione reductase and cytochrome c peroxidase |
Toxoplasma gondii | Distorting in tachyzoites’ shape, peeling, erosions and discontinuity in areas of surface membrane |
Trypanosoma | Unknown |
Anticancer | Glioma | Inducing oxidative DNA lesions and DNA double-strand breaks |
Neuroblastoma | Inducing apoptosis and reactive oxygen species in neuroblastoma cells |
Schwannoma | Inducing cell death dependent on necroptosis |
Neurofibromatosis | Binding to and degrading translationally controlled tumor protein |
Growth hormone adenoma | Inhibiting proliferation and inducing apoptosis by caspase-dependent pathways |
Anti-inflammation | Neuroinflammatory | Influencing NF-kB, p38 MAPK and Nrf2/ARE-dependent signal pathway |
Antivirus | Cytomegalovirus | Interfering with the NF-κB pathway by targeting RelA/p65 |
Ebola virus | Unknown |
Epstein-Barr virus | Blocking viral immediate early protein synthesis |
Herpes virus | Unknown |
Polyomavirus | Leading to cytostatic effects on the host cell |
Others | Subarachnoid hemorrhage | Protecting BBB via S1P1/PI3K pathway after subarachnoid hemorrhage |
Vascular | (1) Inhibiting VSMCs proliferation by disturbing DNA replication, inducing cell apoptosis and blocking cell cycle in G0/G1 phase (2) Inducing apoptosis of endothelial cells via an iron/ROS-dependent p38 MAPK-mitochondrial pathway (3) Inhibiting NF-κB nuclear translocation and the subsequent expression of ICAM-1 |
|
Dihydroartemisinin | Antiparasites | Plasmodium | (1) Generating highly reactive carbon-centered radicals via endoperoxide cleavage (2) Causing the pigment of P. berghei to clump | Contragestational effects Embryotoxicity Erythroid cell differentiation Hemolysis Immunosuppressive activity Neurotoxicity Suppression of humoral responses |
Naegleria fowleri | Unknown |
Schistosoma | Causing damage to the genital system of worms |
Toxoplasma gondii | Unknown |
Anticancer | Neuroblastoma | Damaging mitochondrial cristae and endoplasmic reticulum |
Glioma | (1) Inhibiting the Raf/ERK/MEK, ADAM17, PI3K/AKT pathways and activating caspase-3 (2) Increasing the reactive oxygen species and inhibiting hypoxia inducible factor-1α activation |
Others | Neurite outgrowth | Activating ERK and p38 MAPK signaling pathways |
Vascular | (1) Inhibiting VEGF-induced EC migration via a p38 MAPK-independent pathway (2) Repressing the NF-κB pathway |
|
Artemiside | Antiparasites | Plasmodium | Unknown | Unknown |
Toxoplasma gondii | Unknown |
|
Artemisitene | Antiparasites | Plasmodium | Unknown | Unknown |
Trypanosoma | Unknown |
Anticancer | Tumor of the central nervous system | Inducing iron-dependent cell death |
|
Artemisone | Antiparasites | Plasmodium | Resulting in antimalarial activities by the Fe2+-mediated decomposition, PfATP6 binding | Embryotoxicity Cardiac ventricular septal defects Vascular variation |
Toxoplasma gondii | Unknown |
|
Artefenomel (OZ439) | Antiparasites | Plasmodium | Activating hemoglobin degradation | Unknown |
|
Arterolane (OZ277) | Antiparasites | Plasmodium | Activating hemoglobin degradation | Embryotoxicity |
Schistosoma | Unknown |
|
Arteanuin B | Anticancer | Tumor of the central nervous system | Inducing iron-dependent cell death | Unknown |
Others | Vascular | Inhibiting immune mediators of angiogenesis |
|
SM735 | Anti-inflammation | Immunosuppressive activity | Inhibiting the proliferation of splenocytes, proinflammatory cytokine production, T cell-mediated delayed-type hypersensitivity (DTH) and B-cell-mediated QHS reactions | Unknown |
|
SM905 | Anti-inflammation | Immunosuppressive activity | Inhibiting T cell activation, NO and proinflammatory cytokine production by suppressing and Ras activation, MAPK and NF-kappaB pathways | Unknown |
|
SM933 | Anti-inflammation | Autoimmune encephalomyelitis | Involving the NF-kB and the Rig-G/JAB1 signaling pathways | Unknown |
|
SM934 | Anti-inflammation | Autoimmune encephalomyelitis Immunosuppressive activity | Inducing Treg differentiation and expansion Inhibiting T cell activation | Unknown |
|
Artemisinin dimer 1 | Anticancer | Tumor of the central nervous system | Inducing iron-dependent cell death | Unknown |
|
Artemisinin dimer 2 | Anticancer | Tumor of the central nervous system | Inducing iron-dependent cell death | Unknown |
|
Artemisinin dimer hemisuccinate | Anticancer | Tumor of the central nervous system | Inducing iron-dependent cell death | Unknown |
|
Artesunate derivative | Anticancer | Tumor of the central nervous system | Inducing iron-dependent cell death | Unknown |
|
CPM-1 | Antiparasites | Plasmodium | Unknown | Unknown |
|
11-Azaartemisinins | Antiparasites | Plasmodium | Unknown | Unknown |
|
10-Aminoethylether derivatives of artemisinin | Antiparasites | Plasmodium | Unknown | Unknown |
|
Artefanilide | Antivirus | Cytomegalovirus | Unknown | Unknown |
|